Skip to content
  • Sunday, 26 July 2026
  • 3:41 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential

Lana Keisha Jun 17, 2026 0

Traumatic brain injury (TBI) represents a formidable global public health challenge, impacting an estimated 69 million individuals each year across…

Read More
Neuroscience & Brain Research

Copper drug clears toxic Alzheimer’s proteins and restores memory

Rifan Muazin Jun 16, 2026 0

In a significant advancement for neuropharmacology, researchers at Monash University have identified a copper-based drug candidate that demonstrates a dual-action…

Read More
Neuroscience & Brain Research

Common Joint Supplement Glucosamine Linked to Accelerated Alzheimer’s Progression in New University of Florida Research

Rifan Muazin Jun 15, 2026 0

New scientific evidence from the University of Florida suggests that glucosamine, a widely consumed over-the-counter supplement primarily marketed for joint…

Read More
Neuroscience & Brain Research

Cancer Driving Mutations in Brain Immune Cells Linked to Alzheimer’s Disease Progression and Risk

Rifan Muazin Jun 13, 2026 0

The traditional understanding of Alzheimer’s disease has long centered on the accumulation of amyloid-beta plaques and tau tangles within the…

Read More
Neuroscience & Brain Research

Molecular Switch in Brain Immune Cells Identified as Potential Driver of Alzheimer’s Disease Progression

Rifan Muazin May 31, 2026 0

In a significant advancement for neurobiology, researchers at Scripps Research have uncovered a specific molecular mechanism that triggers chronic brain…

Read More
Neuroscience & Brain Research

CBD Shows Promise in Mitigating Neuroinflammation and Targeting Alzheimer’s Disease Progression

Rifan Muazin May 31, 2026 0

New clinical insights published in the journal eNeuro suggest that cannabidiol (CBD), a non-psychoactive compound derived from the cannabis plant,…

Read More
Laboratory Automation & Robotics

Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential

Lana Keisha May 30, 2026 0

Traumatic brain injury (TBI) stands as a profound and pervasive global health crisis, impacting an estimated 69 million individuals each…

Read More
Clinical Diagnostics & Pathology

Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs

Reynand Amr Wu May 29, 2026 0

A significant new longitudinal study suggests a compelling association between higher vitamin D levels in midlife and reduced accumulation of…

Read More
Biotech & Genetic Research

Memory Decline After Menopause Linked to Loss of Estrogen Production in Brain Tissue, Shedding Light on Alzheimer’s Risk in Women

Jia Lissa May 28, 2026 0

A groundbreaking preclinical study conducted by Northwestern Medicine researchers has unveiled a critical link between the decline of estrogen production…

Read More
Biotech & Genetic Research

Recent Biotech Bi-Weekly Highlights Breakthroughs in Alzheimer’s Modeling and Lab Automation, Fueling Drug Discovery Hopes

Jia Lissa May 27, 2026 0

In a significant development for neurodegenerative disease research, 28bio, a biotechnology firm based in Los Angeles, USA, has announced the…

Read More

Posts pagination

1 … 3 4 5 … 9
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data PlatformJohns Hopkins Study Reveals How Liquid Droplets Formed by Fusion Genes Drive Rare Kidney Cancer ProgressionMolecular Switch FLI-1 Identified as Key Driver for Blood Stem Cell Regeneration and Enhanced Bone Marrow TransplantsDonor-Derived Cell-Free DNA Testing Revolutionizes Post-Transplant Surveillance, Offering Early Organ Injury Detection and Reducing Invasive Biopsies
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ